共 699 条
[1]
Zhang P(1999)The use of arsenic trioxide (As J Biol Regul Homeost Agents 13 195-200
[2]
Agis H(1999)O Ann Hematol 78 329-332
[3]
Weltermann A(1997)) in the treatment of acute promyelocytic leukemia Blood 89 3354-3360
[4]
Mitterbauer G(1998)Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia Am J Pathol 153 1775-1785
[5]
Thalhammer R(2000)Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients J Environ Pathol Toxicol Oncol 19 281-286
[6]
Edelhauser M(2000)Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors J Environ Pathol Toxicol Oncol 19 129-138
[7]
Seewann HL(2000)Mechanisms of arsenic carcinogenicity: Genetic or epigenetic mechanisms? Environ Health Perspect 108 655-661
[8]
Valent P(2000)Predisposing factors in occupational lung cancer: Inorganic minerals and chromium Cancer Invest 18 174-182
[9]
Lechner K(1989)Risk of internal cancers from arsenic in drinking water Biol Trace Elem Res 21 421-429
[10]
Fonatsch C(1996)Arsenic in drinking water and bladder cancer Cancer Lett 98 227-231